CTLT  valuation analysis

Basics
Name: Catalent, Inc
Description: Catalent, Inc., together with its subsidiaries, provides delivery technologies and development solutions for drugs, biologics, and consumer and animal health products worldwide. (more)
Industry: Drug Manufacturers-Specialty & Generic
Last 10Q10Qs are quarterly reports which contain a company's financial figures. We use these to calculate the FFER.: May 04, 2021
Market cap: $18.68B (353rd)
Sales(TTM): $3.76B (542nd)
Earnings(TTM): $556.80M (365th)

Value
FFER: 2.12 (why)
Actual price: $109.70
FFEThis is Catalent, Inc's the estimated price. FFEs are the denominator of the FFER ratio.: $51.74
Quantile: CTLT is very expensive given its fundamentals.
Prices as of EOD 2021-07-15
Price & Estimates
Sales & Earnings history (TTM)
Notable
No notables found through heuristics.
Earnings / MarketCap
Catalent, Inc
"Drug Manufacturers-Specialty & Generic" industry
Sales / MarketCap
Catalent, Inc
"Drug Manufacturers-Specialty & Generic" industry
Book / MarketCap
Catalent, Inc
"Drug Manufacturers-Specialty & Generic" industry
Equity / Assets
Catalent, Inc
"Drug Manufacturers-Specialty & Generic" industry